J Robert Sneyd
Overview
Explore the profile of J Robert Sneyd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
331
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sneyd J, Valk B
Br J Anaesth
. 2025 Jan;
134(1):11-13.
PMID: 39756850
Etomidate, an intravenous hypnotic used for anaesthesia and critical care, is known for its undesirable side effects, including pain on injection, myoclonus, and adrenocortical depression. Despite its continued clinical use...
2.
3.
Remimazolam and Ciprofol: More Research Is Needed but Ask the Right Questions and Perhaps Aim Higher
Sneyd J, Anderson B
Anesthesiology
. 2024 Nov;
141(6):1034-1038.
PMID: 39530717
No abstract available.
4.
El-Boghdadly K, Desai N, Jones J, Elghazali S, Ahmad I, Sneyd J
Anaesthesia
. 2024 Oct;
80(1):74-84.
PMID: 39468765
Background: Different sedation regimens have been used to facilitate awake tracheal intubation, but the evidence has not been synthesised robustly, particularly with respect to clinically important outcomes. We conducted a...
5.
Sneyd J
Br J Anaesth
. 2024 Jun;
133(1):16-18.
PMID: 38879265
Anaesthesia induced with remimazolam and a fentanyl-series opioid can be reversed with flumazenil and naloxone. Concomitant paralysis with rocuronium can facilitate tracheal intubation whilst being reversible with sugammadex. Together, this...
6.
Sneyd J
Curr Opin Anaesthesiol
. 2024 Jun;
37(4):391-397.
PMID: 38841982
Purpose Of Review: Drug development to support anaesthesia and sedation has been slow with few candidates emerging from preclinical discovery and limited innovation beyond attempted reformulation of existing compounds. Recent...
7.
Hunter J, Sneyd J
Br J Anaesth
. 2024 Jan;
132(1):15-17.
PMID: 38171649
Sugammadex is now in widespread use to reverse the neuromuscular blocking effects of rocuronium. Adverse effects from sugammadex are rare, but anaphylactic and cardiovascular reactions to the drug have been...
8.
Sorrell L, Leta V, Barnett A, Stevens K, King A, Inches J, et al.
PLoS One
. 2023 Jul;
18(7):e0285349.
PMID: 37523365
Background: Parkinson's disease has been identified as a risk factor for severe Coronavirus disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death from COVID-19 in people with...
9.
Sneyd J
Br J Anaesth
. 2022 Sep;
129(5):649-651.
PMID: 36057481
Rapid elimination of remifentanil facilitates application of intense opioid effect during general anaesthesia whilst maintaining prompt emergence. Interruptions in remifentanil supply mean clinicians must relearn titration of pharmacokinetically longer-acting opioids...
10.
Sneyd J, Absalom A, Barends C, Jones J
Br J Anaesth
. 2022 May;
129(2):e25-e27.
PMID: 35618536
No abstract available.